drugset / Trial / NCT03335072
Kebele Elimination of Trachoma for Ocular Health
Phase 4
Active not recruiting
320000 enrolled
University of California, San Francisco
Bahir Dar University · collabEyu-Ethiopia · collabNational Eye Institute (NEI) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The investigators propose a cluster-randomized clinical trial to determine whether an intensive, targeted azithromycin distribution strategy is effective for elimination of trachoma at the kebele level compared to the World Health Organization (WHO) recommendation of annual azithromycin distribution.
Timeline
- Start
- 2022-02-07
- Primary completion
- 2027-03-01
- Completion
- 2028-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azithromycin | Small molecule | — | — |